Ellen Goldbloom

Investigator, CHEO Research Institute

Ellen Goldbloom has been an active member of the Division of Endocrinology at CHEO since 2011. She received her medical degree from Dalhousie University and completed her pediatric residency and pediatric endocrinology fellowship at CHEO and the University of Ottawa. Her current CHEO leadership roles include Ambulatory Care Medical Director, Deputy Chief Medical Information Officer, Virtual Care & Patient Portal Medical Lead and EpicCare Ambulatory Leadership Team Medical Lead. Internationally, she has been a member of the Epic (EHR) Pediatric Endocrinology Specialty Steering Board since 2015 and is currently Chair. In these roles, she has led several eHealth improvements with a focus on improving productivity, streamlining care, optimizing quality of care, and setting the stage for easily searchable data with evaluative/research potential.

Other Areas of Research: Adrenal suppression, delivery of care leveraging digital tools to improve quality of care

Research Projects

  1. A pediatric virtual care evaluation framework and its evolution using consensus methods

    17/08/2023

    The use of virtual care has increased dramatically in response to the COVID-19 pandemic, yet evidence is lacking regarding the impact of virtual care on patient outcomes, particularly in pediatrics. A standardized evaluation approach is required to support the integration of virtual care into pediatric health care delivery programs. The objective of this work was to develop a comprehensive and structured framework for pediatric virtual care evaluation. This framework is intended to engage and guide care providers, health centres, and stakeholders towards the development of a standardized approach to the evaluation of pediatric virtual care.

  2. Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting

    12/04/2023

    Initiation of Control-IQ technology in a real-world setting significantly reduced the impact of diabetes on daily life while simultaneously improving glycemic control

  3. Innovative Virtual Care Delivery in a Canadian Pediatric Tertiary Care Centre; Pediatrics & Child Health

    06/05/2022

  4. Social determinants of health linked with patient portal use in pediatric diabetes

    12/04/2022

  5. Patient and family perspective of a Pre-Transition Visit in a pediatric tertiary care diabetes clinic

    31/01/2022

    Overall, we found that both patients and their families had high levels of satisfaction with the Pre-T Visit which reinforced this as a good use of resources (ie, patient, administrative and educator time) in our clinic, with respect to the patient experience. These findings were consistent across patients despite differences in age, gender, diabetes duration and A1C. Furthermore, patients reported high levels of engagement/participation in the visit.